Abstract
Recent studies have described an increase in the incidence of complicated pneumonia in children, primarily caused by Streptococcus pneumoniae. The objective of this study was to determine if the incidence of complicated pneumonias in total and due to different pneumococcal serotypes has changed following the introduction of routine immunization with heptavalent pneumococcal conjugate vaccine (PCV7). A retrospective review of patients admitted to the Stollery Children’s Hospital in Edmonton, Alberta with complicated pneumonia between July 1, 1997 and June 30, 2007 (5 years before and after the introduction of PCV7) was completed. There were 34 children in the pre- and 68 in the post-PCV7 era (14.31 and 19.91 per 10,000 discharges, respectively, p = 0.114). Patient characteristics were not significantly different, and pneumococcus was the most common organism isolated (pre: 21% (7/34); post: 26% (18/68), p = 0.515). In patients where serotype data was available, non-vaccine pneumococcal serotypes accounted for 67% (12/18) cases in the post-PVC7 era versus 14% (1/7) in the pre-PCV7 era (p = 0.031). The incidence of non-vaccine serotypes was 0.42 and 3.51 per 10,000 discharges in the pre- and post-PCV7 eras, respectively (p = 0.020). There has been a non-significant trend towards an increase in the incidence of complicated pneumonia following the introduction of PCV7. S. pneumoniae remains the predominant organism identified with non-vaccine serotypes now accounting for almost all cases. Although it is not clear if this increase is attributable to the use of PCV7, expanding pneumococcal serotype coverage has the potential to prevent complicated pneumonia.
Similar content being viewed by others
References
Advisory Committee on Immunization Practices (2000) Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 49(RR-9):1–35
Alberta Health and Wellness Website on Immunizations. http://www.health.gov.ab.ca/public/immunization.html. Accessed July 2008
Ampofo K, Bender J, Sheng X et al (2008) Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 122(2):229–237
Buckingham SC, King MD, Miller ML (2003) Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 22(6):499–504
Byington CL, Korgenski K, Daly J et al (2006) Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 25(3):250–254
Byington CL, Samore MH, Stoddard GJ et al (2005) Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 41(1):21–29
Byington CL, Spencer LY, Johnson TA et al (2002) An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis 34(4):434–440
Centers for Disease Control and Prevention (CDC) (2009) Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine—United States, 1997–2006. MMWR Morb Mortal Wkly Rep 58(1):1–4
Centers for Disease Control and Prevention (CDC) (2008) Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction—eight states, 1998–2005. MMWR Morb Mortal Wkly Rep 57(6):144–148
Dagan R (2009) Serotype replacement in perspective. Vaccine 27(Suppl 3):C22–C24
Fletcher M, Leeming J, Cartwright K et al (2006) Childhood empyema: limited potential impact of 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 25(6):559–560
Goldbart AD, Leibovitz E, Porat N et al (2009) Complicated community acquired pneumonia in children prior to the introduction of the pneumococcal conjugated vaccine. Scand J Infect Dis 41(3):182–187
Harboe ZB, Benfield TL, Valentiner-Branth P et al (2010) Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clin Infect Dis 50(3):329–337
Hendrickson DJ, Blumberg DA, Joad JP et al (2008) Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 27(11):1030–1032
Hicks LA, Harrison LH, Flannery B et al (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 196:1346–1354
Jansen AG, Sanders EA, van der Ende A et al (2008) Invasive pneumococcal and meningococcal disease: association with influenza virus and respiratory syncitial virus activity. Epidemiol Infect 136(11):1448–1454
Karlowsky JA, Lagacé-Wiens PR, Low DE et al (2009) Annual macrolide prescription rates and the emergence of macrolide resistance among Streptococcus pneumoniae in Canada from 1995 to 2005. Int J Antimicrob Agents 34(4):375–379
Kellner JD, Vanderkooi OG, MacDonald J et al (2009) Changing epidemiology of invasive pneumococcal disease in Canada, 1998–2007: update from the Calgary area Streptococcus pneumoniae research (CASPER) study. Clin Infect Dis 49(2):205–212
Langley JM, Kellner J, Solomon N et al (2008) Empyema associated with community-acquired pneumonia: a Pediatric Investigator’s Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 8:129
Li ST, Tancredi DJ (2010) Empyema hospitalizations increased in US despite pneumococcal conjugate vaccine. Pediatrics 125(1):26–33
Rees JH, Spencer DA, Parikh D et al (1997) Increase in incidence of childhood empyema in West Midlands, UK. The Lancet 349:402–404
Rennels MB, Edwards KM, Keyserling HL et al (1998) Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101:604–611
Schultz KD, Fan LL, Pinsky J et al (2004) The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 113(6):1735–1740
Tan TQ, Mason EO Jr, Wald ER et al (2002) Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics 110(1 Pt 1):1–6
Tarrago D, Fenoll A, Sanchez-Tatay D et al (2008) Identification of pneumococcal serotypes from culture-negative clinical specimens by novel real-time PCR. Clin Microbiol Infect 14(9):828–834
Tsai CJ, Griffin MR, Nuorti JP et al (2008) Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis 46(11):1664–1672
Tyrell GJ, Lovgren M, Chui N et al (2009) Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006. Vaccine 27(27):3553–3560
Van Ackere T, Proesmans M, Vermeulen F et al (2009) Complicated parapneumonic effusion in Belgian children: increased occurrence before routine pneumococcal vaccine implementation. Eur J Pediatr 168:51–58
Van Gils EJ, Veenhoven RH, Hak E et al (2009) Effect of reduced-dose schedules with a 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized control trial. JAMA 302(2):159–167
Whitney CG, Farley MM, Hadler J et al (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348(18):1737–1746
Winther TN, Kristensen TD, Kaltoft MS et al (2008) Invasive pneumococcal disease in Danish children, 1996–2007, prior to the introduction of heptavalent pneumococcal conjugate vaccine. Acta Paediatr 98(2):328–331
Conflict of interest
The authors have no conflicts of interests to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chibuk, T.K., Robinson, J.L. & Hartfield, D.S. Pediatric complicated pneumonia and pneumococcal serotype replacement: trends in hospitalized children pre and post introduction of routine vaccination with Pneumococcal Conjugate Vaccine (PCV7). Eur J Pediatr 169, 1123–1128 (2010). https://doi.org/10.1007/s00431-010-1195-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-010-1195-6